Ovarian fibrosis in polycystic ovary syndrome: Mechanisms, evidences, and clinical implications
Differentiation · 2026-07 · 150 · 100976
DOI: 10.1016/j.diff.2026.100976 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Differentiation, 2026-07. Verfasst von Sakshi Nalkande und 3 weiteren Autor:innen. Beteiligte Einrichtung: SVKM NMIMS Global University School of Pharmacy and Technology Management, Dhule, Maharashtra, 424001, India. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Fibrosis, Ovary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 115 Literaturangaben.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a complex heterogeneous endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Emerging studies suggest that ovarian fibrosis, as an underrecognized pathological feature, may contribute to ovarian dysfunction and infertility in PCOS phenotypes. Available experimental and limited human studies indicate that hyperandrogenism, insulin resistance, chronic low-grade inflammation, oxidative and endoplasmic reticulum stress collectively promote extracellular matrix accumulation and stromal remodeling predominantly through transforming growth factor-β (TGF-β)-mediated signaling pathways. Additionally, fibrotic remodeling has been linked to other pathways, including the NLRP3 inflammasome, PI3K/Akt, Hippo/YAP, and epithelial-mesenchymal transition. Although standardised diagnostic criteria are currently lacking, new imaging modalities, such as shear-wave elastography, and circulating fibrosis-related biomarkers may offer non-invasive approaches to evaluating ovarian fibrotic alterations. Furthermore, several anti-fibrotic agents, metabolic modulators, phytochemicals, and stem cell-based therapies have been suggested to have potential therapeutic effects in ovarian fibrosis models of PCOS. Overall, ovarian fibrosis represents a developing aspect of PCOS pathophysiology that requires further clinical and translational investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SVKM NMIMS Global University School of Pharmacy and Technology Management, Dhule, Maharashtra, 424001, India.
- SVKM NMIMS Global University School of Pharmacy and Technology Management, Dhule, Maharashtra, 424001, India. Electronic address: Sameer.Goyal@svkm.ac.in.
Zitieren
APA
Nalkande, S., Patil, M., Nakhate, K., & Goyal, S. (2026). Ovarian fibrosis in polycystic ovary syndrome: Mechanisms, evidences, and clinical implications. Differentiation, 150, 100976. https://doi.org/10.1016/j.diff.2026.100976
Vancouver
Nalkande S, Patil M, Nakhate K, Goyal S. Ovarian fibrosis in polycystic ovary syndrome: Mechanisms, evidences, and clinical implications. Differentiation. 2026;150:100976. doi:10.1016/j.diff.2026.100976
BibTeX
@article{Nalkande2026,
author = {Nalkande, Sakshi and Patil, Mrudula and Nakhate, Kartik and Goyal, Sameer},
title = {Ovarian fibrosis in polycystic ovary syndrome: Mechanisms, evidences, and clinical implications},
journal = {Differentiation},
year = {2026},
volume = {150},
pages = {100976},
doi = {10.1016/j.diff.2026.100976}
}
EUVIMED